The current position and the future perspectives of cervical cancer screening

摘要: Cervical screening programs for detecting cancer and precancer have dramatically reduced the incidence mortality rates of cervical since 1960s. The efficacy depends on participation accuracy tests. Unfortunately, are suboptimal; more than half women with not or only sporadically been screened. Increasing is best way maximizing program's benefit. Furthermore, cytology lacks high sensitivity high-grade intraepithelial neoplasia (≥CIN2). High-risk human papillomavirus (hrHPV) sensitive in detection screening, but less specific, so that additional triage testing still mandatory. aim this article to reflect current promising future strategies primary hrHPV hrHPV-positive results.